Corrigendum to ‘Chemotherapy and PARP inhibitors in heavily pretreated BRCA1/2 mutation ovarian cancer (BMOC) patients’ [Gynecologic Oncology 152 (2019) 270-277] by Rodriguez-Freixinos, V., Fariñas-Madrid, L., Gil-Martin, M., Barretina-Ginesta, P., Romeo, M., Villacampa, G., Pardo, B., Ahmed, H., Recalde, S., Piulats, J.M., Gomez-Plaza, M.C., Gil-Moreno, A., Sala, E., Martínez-Roman, S., Ponce, J., Melendez, C., Carballas, E., Dienstmann, R., Oaknin, A.

Get full text

Chemotherapy and PARP inhibitors in heavily pretreated BRCA1/2 mutation ovarian cancer (BMOC) patients by Rodriguez-Freixinos, V., Fariñas-Madrid, L., Gil-Martin, M., Barretina-Ginesta, P., Romeo, M., Villacampa, G., Pardo, B., Ahmed, H., Recalde, S., Piulats, J.M., Gómez-Plaza, M.C., Gil-Moreno, A., Sala, E., Martínez-Román, S., Ponce, J., Meléndez, C., Carballas, E., Dienstmann, R., Oaknin, A.

Get full text

Detection of lymph node metastases using pooling method by One-Step Nucleic Acid Amplification (OSNA) assay in prostate cancer patients: Preliminary results by Cuadras Sole, M., Planas Morin, J., Celma Domènech, A., Regis Plácido, L., Semidey Raven, M.E., De Torres Ramírez, I.M., Ramón, S., Cajal, S., Congregado Ruiz, B., Baena Villamarín, C., Japón Rodrigues, M.Á., De Álava Casado, E., Marcilla Plaza, D., Martínez-Piñeiro, L., Hardisson, D., González-Peramato, P., García Fernández, E., Buisán Rueda, O., Areal Calama, J., Fernández Ruiz, P.L., Carrato Moñino, C., Gómez-Plaza, M.C., Trilla Herrera, E., Morote Robles, J.

Get full text

Ultrasound and microwave techniques for assisting ageing on lees of red wines by Muñoz García, R., Martínez-Lapuente, L., Guadalupe, Z., Ayestarán, B., Marchante, L., Díaz-Maroto, M.C., Pérez Porras, P., Bautista Ortín, A.B., Gómez-Plaza, E., Pérez-Coello, M.S.

Get full text

Volatile compounds of three Limonium species: L. latifolia, L. x altaica and L. perezii by Soriano Cano, M.C. (Consejeria de Medio Ambiente, Murcia, Spain.), Gomez Plaza, E, Gil Munoz, R, Gonzalez Benavente, A

Get full text